Elicio Therapeutics, Inc. · NASDAQ:ELTX

Knoll Capital Management, LLC reported a 5.20% stake in Elicio Therapeutics, Inc. (Schedule 13G)

Event Jan 30, 2025 · Filed Feb 5, 2025

Knoll Capital Management, LLC reported a 5.20% stake in Elicio Therapeutics, Inc., 630,915 shares, as a passive investor on Jan 30, 2025. Filed Feb 5, 2025 (Schedule 13G).

Stake
5.20%
Shares
630,915
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Knoll Capital Management, LLC5.20%630,915
Fred Knoll5.20%630,915
Gakasa Holdings, LLC5.20%630,915

Source

View original at SEC

Related